Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748

M.C. Adriaanse; F. Pouwer

doi:10.1136/eb-2012-101186

Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748

M.C. Adriaanse, F. Pouwer

Medical and Clinical Psychology

Research output: Contribution to journal › Comment/Letter to the editor › Scientific › peer-review

Original language	English
Pages (from-to)	e44
Journal	Evidence-Based Medicine
Volume	18
DOIs	https://doi.org/10.1136/eb-2012-101186
Publication status	Published - 2013

Access to Document

10.1136/eb-2012-101186

Cite this

Adriaanse, M. C., & Pouwer, F. (2013). Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748. Evidence-Based Medicine, 18, e44. https://doi.org/10.1136/eb-2012-101186

Adriaanse, M.C. ; Pouwer, F. / Screening for type 2 diabetes does not reduce mortality over 10 years : Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748. In: Evidence-Based Medicine. 2013 ; Vol. 18. pp. e44.

@article{d6e6b44723e04f77ab028dc141e76ca1,

title = "Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748",

author = "M.C. Adriaanse and F. Pouwer",

year = "2013",

doi = "10.1136/eb-2012-101186",

language = "English",

volume = "18",

pages = "e44",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

}

Adriaanse, MC & Pouwer, F 2013, 'Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748', Evidence-Based Medicine, vol. 18, pp. e44. https://doi.org/10.1136/eb-2012-101186

Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748. / Adriaanse, M.C.; Pouwer, F.
In: Evidence-Based Medicine, Vol. 18, 2013, p. e44.

Research output: Contribution to journal › Comment/Letter to the editor › Scientific › peer-review

TY - JOUR

T1 - Screening for type 2 diabetes does not reduce mortality over 10 years

T2 - Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748

AU - Adriaanse, M.C.

AU - Pouwer, F.

PY - 2013

Y1 - 2013

U2 - 10.1136/eb-2012-101186

DO - 10.1136/eb-2012-101186

M3 - Comment/Letter to the editor

SN - 1356-5524

VL - 18

SP - e44

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

ER -

Adriaanse MC, Pouwer F. Screening for type 2 diabetes does not reduce mortality over 10 years: Commentary on: Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–1748. Evidence-Based Medicine. 2013;18:e44. doi: 10.1136/eb-2012-101186